Results 301 to 310 of about 276,656 (346)

Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians

open access: yesCA: A Cancer Journal for Clinicians, EarlyView.
Abstract Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer‐related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer‐reviewed guidelines regarding systemic therapy as well as the possibility of downstaging disease that may enable some patients
Dimitrios Moris   +12 more
wiley   +1 more source

The costs and benefits of a prison needle and syringe program in Australia, 2025–30: a modelling study

open access: yesMedical Journal of Australia, Volume 222, Issue 8, Page 396-402, May 2025.
Abstract Objectives To estimate and compare the costs and benefits of introducing a prison needle and syringe program in all Australian prisons. Study design Stochastic compartmental modelling study. Setting All Australian prisons, 1 January 2010 to 31 December 2030.
Farah Houdroge   +6 more
wiley   +1 more source

HCV-related hepatocellular carcinoma: gene signatures associated with TERT promoter mutations and sex. [PDF]

open access: yesJ Transl Med
Bonelli P   +12 more
europepmc   +1 more source

Stigma among primary care providers: characterizing attitudes and behaviors in the care of people with chronic hepatitis in the Philippines. [PDF]

open access: yesBMC Prim Care
Hopkins-Kotb N   +12 more
europepmc   +1 more source

Oral manifestations in patients with chronic hepatitis C. [PDF]

open access: yesBMC Oral Health
Brzdęk M   +8 more
europepmc   +1 more source

Current advances 2024: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

open access: yes
Transfusion, EarlyView.
Elizabeth P. Crowe   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy